Cargando…
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8
SIMPLE SUMMARY: Trisomy 8 (+8) is one of the most frequent cytogenetic alterations found in myelodysplastic syndromes (MDS). MDS patients harboring isolated +8 show clinical heterogeneity, and life expectancy varies between several months and several years after diagnosis. We aimed to investigate wh...
Autores principales: | Toribio-Castelló, Sofía, Castaño, Sandra, Villaverde-Ramiro, Ángela, Such, Esperanza, Arnán, Montserrat, Solé, Francesc, Díaz-Beyá, Marina, Díez-Campelo, María, del Rey, Mónica, González, Teresa, Hernández-Rivas, Jesús María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417840/ https://www.ncbi.nlm.nih.gov/pubmed/37568638 http://dx.doi.org/10.3390/cancers15153822 |
Ejemplares similares
-
P714: DISSECTING THE CLINICAL HETEROGENEITY OF ISOLATED TRISOMY 8 MYELODYSPLASTIC SYNDROMES THROUGH MUTATIONAL PROFILE
por: María Toribio Castelló, Sofía, et al.
Publicado: (2023) -
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
por: Saumell, Sílvia, et al.
Publicado: (2015) -
PB1997: TRISOMY 18 IN MYELODYSPLASTIC SYNDROMES
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2023) -
The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome
por: Oka, Satoko, et al.
Publicado: (2020) -
Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
por: Cedena, M. Teresa, et al.
Publicado: (2017)